We are live on ! Find out more
PKBO

Peak Bio, Inc. Common Stock
PKBO

Delisted

PKBO was delisted on the 9th of January, 2023.

Back to rankings

40 hedge funds and large institutions have $38.4M invested in Peak Bio, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 4

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

12% more capital invested

Capital invested by funds: $34.3M → $38.4M (+$4.07M)

11% more funds holding

Funds holding: 36 → 40 (+4)

Holders
40
Holders Change
+4
Holders Change %
+11.11%
% of All Funds
0.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
11
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Shaolin Capital Management
Florida
+$1.86M
2
SCM
Saba Capital Management
New York
+$1.2M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$810K
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$573K
5
CCM
Context Capital Management
California
+$491K

Top Sellers

Rank Fund Capital Flow
1
KPF
K2 Principal Fund
Ontario, Canada
-$4.02M
2
Millennium Management
Millennium Management
New York
-$277K
3
BI
Bulldog Investors
New Jersey
-$244K
4
HIH
HRS Investment Holdings
New York
-$157K
5
CM
Cohanzick Management
New York
-$9.81K
Name Holding Trade Value Shares
Change 		Change in
Stake
AA
26
AQR Arbitrage
Connecticut
$344K – – –
Goldman Sachs
27
Goldman Sachs
New York
$270K +$32.1K +3,276 +14%
Barclays
28
Barclays
United Kingdom
$212K +$212K +21,583 New
Walleye Capital
29
Walleye Capital
New York
$209K -$7.8K -795 -4%
RCM
30
Rivernorth Capital Management
Florida
$197K – – –
HF
31
HRT Financial
New York
$196K +$196K +19,993 New
OMC
32
Old Mission Capital
Illinois
$173K +$43.3K +4,409 +33%
CFIA
33
Cantor Fitzgerald Investment Advisors
New York
$158K – – –
Walleye Trading
34
Walleye Trading
New York
$157K – – –
Millennium Management
35
Millennium Management
New York
$148K -$277K -28,235 -65%
RA
36
RiverPark Advisors
New York
$134K – – –
Ohio Public Employees Retirement System (OPERS)
37
Ohio Public Employees Retirement System (OPERS)
Ohio
$30K +$29.4K +3,000 New
UBS Group
38
UBS Group
Switzerland
$25K +$5.6K +571 +29%
TRCT
39
Tower Research Capital (TRC)
New York
$1K – – –
ASM
40
ATW SPAC Management
New York
$984 – – –
KPF
41
K2 Principal Fund
Ontario, Canada
– -$4.02M -412,651 Closed
BI
42
Bulldog Investors
New Jersey
– -$244K -25,000 Closed
HIH
43
HRS Investment Holdings
New York
– -$157K -16,034 Closed
1
2

PKBO Hedge Fund Activity: Q1 2022 in Review

40 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Peak Bio, Inc. Common Stock (PKBO) for Q1 2022, worth a combined $38.4M — up 12% from $34.3M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new PKBO positions and 3 closed out — a net gain of 4 holders — while 11 added to existing stakes and 4 trimmed.

The largest buyer was Shaolin Capital Management, opening a new position worth an estimated $1.86M. The largest seller was K2 Principal Fund, exiting entirely with an estimated $4.02M sold.

  • 40 institutional investors held Peak Bio, Inc. Common Stock (PKBO) as of Q1 2022, up from 36 in Q4 2021.
  • Funds reported $38.4M of Peak Bio, Inc. Common Stock stock for Q1 2022, up 12% quarter-over-quarter.
  • 7 funds opened new Peak Bio, Inc. Common Stock positions in Q1 2022 and 3 closed out, a net change of +4 holders.
  • The largest Peak Bio, Inc. Common Stock buyer in Q1 2022 was Shaolin Capital Management, an estimated $1.86M added.
  • The largest Peak Bio, Inc. Common Stock seller in Q1 2022 was K2 Principal Fund, an estimated $4.02M sold.

Based on aggregated 13F filings for Q1 2022.